RAPHAS is a biotechnology company headquartered in Seoul, South Korea, specializing in the development of next-generation microneedle-based drug delivery systems for pharmaceutical and immunological applications. Leveraging its proprietary technology, the company offers a painless, convenient, and effective transdermal drug delivery platform designed to replace conventional injection-based methods...